Anaptysbio, Inc.

ANAB Nasdaq SEC CIK 1370053
Follow Anaptysbio Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $30.3M −60.3% vs same quarter last year
Net income $3.9M −74.4% vs same quarter last year
EPS, diluted $0.11 −78.8% vs same quarter last year
Operating cash flow −$9.5M +65.1% vs same quarter last year
Revenue by quarter
$43.1M
$27.8M
$22.3M
$76.3M
$108.2M
$25.6M
$27.5M
$30.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income12 fiscal years
  • Revenue
  • Net income
−$200M−$100M$0$100M$200M$300MFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$234.6M−$13.2M
FY24$91.3M−$145.2M
FY23$17.2M−$163.6M
FY22$10.3M−$128.7M
FY21$63.2M−$57.8M
FY20$75M−$19.9M
FY19$8M−$97.3M
FY18$5M−$61.7M
FY17$10M−$30.1M
FY16$16.7M−$4.3M
FY15$17.6M−$5.4M
FY14--
MarginsShare of revenue
  • Operating margin
  • Net margin
−1500%−1000%−500%0%500%FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY2596.7%−5.6%
FY2472.5%−159.1%
FY23−958.3%−953.7%
FY22−1119.4%−1251.3%
FY21−89.9%−91.5%
FY20−31.8%−26.6%
FY19−1342.9%−1216.7%
FY18−1334.4%−1233.1%
FY17−287.8%−300.7%
FY16−18.1%−25.5%
FY15−18.9%−30.8%
FY14--
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0$50MFY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$19.6M
FY24−$135.7M
FY23−$121.6M
FY22−$74M
FY21−$47.3M
FY20−$14.7M
FY19−$70.3M
FY18−$49.6M
FY17−$19.7M
FY16−$9.1M
FY15−$9.9M
FY14-
Returned to shareholdersDividends paid and shares bought back
$0$20M$40M$60M$80MFY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$68.6M
FY24$456K
FY23$50M
FY22$0
FY21$0
FY20-
FY19-
FY18$0
FY17$0
FY16$1K
FY15$0
FY14-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Anaptysbio
  • Healthcare median
−1500%−1000%−500%0%FY15FY17FY19FY21FY23FY25
Show the numbers
YearAnaptysbioHealthcare median
FY25−5.6%−30.6%
FY24−159.1%−47%
FY23−953.7%−58%
FY22−1251.3%−80.4%
FY21−91.5%−71.8%
FY20−26.6%−62.2%
FY19−1216.7%−46.2%
FY18−1233.1%−49.6%
FY17−300.7%−45.9%
FY16−25.5%−36%
FY15−30.8%−37.8%
FY14-−35.5%